文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

南非高HIV流行区先天性巨细胞病毒感染与宫内HIV感染风险

Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该研究在南非索韦托筛查2685名新生儿的唾液CMV PCR,确诊先天性巨细胞病毒(cCMV)感染率为2.5%,HIV暴露新生儿cCMV感染率5.2%显著高于非暴露者1.4%;HIV暴露且cCMV感染新生儿的宫内HIV感染风险约为20倍升高,且与母亲CD4+ T细胞计数及ART疗程无关。

要点

  • HIV暴露新生儿cCMV感染率显著高于非暴露者,应关注该人群的CMV筛查。
  • cCMV感染使HIV暴露新生儿的宫内HIV感染风险约升高20倍。
  • 该风险升高与母亲CD4+ T细胞计数及ART使用时长无关。

核心结论

  • 南非索韦托cCMV感染率2.5%,显著高于全球估计的0.64%,部分归因于HIV暴露新生儿的易感性增加。
  • cCMV合并感染与HIV暴露新生儿宫内HIV感染风险约20倍升高相关,提示CMV在ART时代仍参与宫内HIV传播的残余负担。

研究设计与样本

  • 前瞻性筛查研究,对2685名新生儿出生时采集唾液以PCR筛查CMV,阳性者3周内复采唾液和尿液确认。
  • 对HIV暴露新生儿全血行HIV PCR检测,并从临床记录提取母亲与新生儿数据。

主要发现

  • 2685名新生儿中828名(31%)为HIV感染母亲所生,其中95%(790/828)在分娩时使用ART。
  • cCMV总感染率为2.5%(95%CI 1.9-3.2),HIV暴露新生儿为5.2%(95%CI 3.8-6.9),非暴露新生儿为1.4%(95%CI 0.9-2.0)。
  • HIV暴露且cCMV感染新生儿的宫内HIV感染风险更高(OR 20.1,95%CI 6.09-66.46)。
  • 该风险升高与母亲CD4+ T细胞计数及ART使用时长无关。

临床怎么用

  • 在高HIV流行地区,对HIV暴露新生儿应考虑CMV筛查,以识别cCMV合并感染。
  • 对cCMV感染的HIV暴露新生儿应加强宫内HIV感染的评估与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of data on the burden of congenital cytomegalovirus (cCMV) infections in low- and middle-income countries, including their association with maternal human immunodeficiency virus (HIV) infections. We investigated the prevalence of cCMV in a patient population with a high rate of HIV and antiretroviral therapy (ART) use during pregnancy in Soweto, Johannesburg. METHODS: Saliva from neonates were screened for cytomegalovirus (CMV) infection by polymerase chain reaction (PCR) at birth. Additional saliva and urine samples were tested within 3 weeks of birth to confirm positive saliva results. HIV PCR testing was done on the whole blood of HIV-exposed neonates. Maternal and neonatal data were extracted from clinical records. RESULTS: Of 2685 neonates screened for cCMV, 828 (31%) were born to HIV-infected women, 95% of whom (790/828) were on ART at delivery. The overall prevalence of cCMV was 2.5% (95% confidence interval [CI] 1.9-3.2), with significantly higher cCMV prevalence in HIV-exposed neonates (5.2%, 95% CI 3.8-6.9) than HIV-unexposed neonates (1.4%, 95% CI 0.9-2.0). The risk of in utero HIV infection was 20-fold greater (odds ratio 20.1, 95% CI 6.09-66.46) in HIV-exposed, cCMV-infected neonates, and this increased risk was not associated with the maternal CD4+ T-cell count or the maternal duration of ART. CONCLUSIONS: The prevalence of cCMV in our setting is substantially higher than the global estimate of 0.64%, partly due to the increased susceptibility for cCMV in HIV-exposed neonates. The significantly increased risk of in utero HIV infection in neonates with cCMV indicates that CMV coinfection plays a major role in the residual burden of in utero HIV transmission, even in the era of ART.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Pathirana J, Groome M, Dorfman J, et al. Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa. Clin Infect Dis. 2019. PMID: 30615106. doi:10.1093/cid/ciz019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。